Search
Emicizumab
go.drugbank.com/drugs/DB13923ApprovedInvestigationalEmicizumab was originated as an improved form of hBS23 and it was approved on November 16, 2017.[A31279, L1016] It was created by Chugai Pharmaceuticals Co.
Products: HEMLIBRA 30MG/ML SOLUTION FOR INJECTION, HEMLIBRA 150MG/ML SOLUTION FOR INJECTIONDecitabine
go.drugbank.com/drugs/DB01262ApprovedInvestigational[A2263, A2264, A2265, A215317, L14962] Decitabine was developed by MGI Pharma/SuperGen Inc. and was approved by the FDA for the treatment of MDS on February 5, 2006. … [L14962] It is also available as an oral combination product together with the cytidine deaminase inhibitor [cedazuridine].
Products: DECI SPAL-P 50, DACOGEN (Decitabine) 50 mg Powder for Concentrate for Solution for InfusionAntithymocyte immunoglobulin (rabbit)
go.drugbank.com/drugs/DB00098ApprovedInvestigationalThymoglobulin is a polyclonal antibody that suppresses certain types of immune cells responsible for acute organ rejection in transplant patients.
Products: Thymoglobuline 5mg/ml Powder for concentrate for solution for infusion, Grafalon 20 mg/ml Konzentrat zur Herstellung einer InfusionslösungCefazolin
go.drugbank.com/drugs/DB01327ApprovedInvestigationalA semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: RECEF, CEFAZOLIN ALVOGEN POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/VIALPrednisolone acetate
go.drugbank.com/drugs/DB15566ApprovedInvestigationalVet approvedPrednisolone acetate is a [prednisolone] molecule bound to an acetate functional group by an ester bond.[L9449] Prednisolone acetate was granted FDA approval in 1955.[L9449]
Categories: P-glycoprotein substrates, Cytochrome P-450 SubstratesProducts: Prednisolone Acetate PFDrozitumab
go.drugbank.com/drugs/DB19106InvestigationalIt was developed by Genentech as a drug for the treatment of cancers … Drozitumab is a human monoclonal antibody directed against tumor necrosis factor receptor superfamily member 10B (TNFRSF10B), a member of tumor necrosis factor related apoptosis-inducing ligand (TRAIL)
Synonyms: Usp mab 003, monoclonal igg1, Immunoglobulin g1, anti-(human citokine receptor dr5 (death receptor 5)) (human monoclonal heavy chain), disulfide with human l3-chain, dimerTechnetium Tc-99m sulfur colloid
go.drugbank.com/drugs/DB09397Approveda radiopharmaceutical diagnostic agent used in the evaluation of various conditions including lymph node metastases in breast cancer, detection of shunt patency, imaging of reticuloendothelial cells for
Products: Kit for the Preparation of Technetium Tc 99m Sulfur Colloid, Kit for the Prepartion of Technetium Tc99m Sulfur ColloidRavulizumab
go.drugbank.com/drugs/DB11580ApprovedInvestigational[A244465] It was later approved by the European Commission on July 2, 2019, for the same indications.[L39710] Ravulizumab is also used to treat myasthenia gravis. … [A244465] Ravulizumab was first approved by the FDA on December 21, 2018, for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome in children and adults.
Products: Ultomiris 100mg/mL Concentrate For Solution For InfusionEucalyptol
go.drugbank.com/drugs/DB03852ApprovedInvestigationalNutraceuticalEucalyptol is an effective treatment for nonpurulent rhinosinusitis. Eucalyptol reduces inflammation and pain when applied topically. It kills leukaemia cells in vitro. … Eucalyptol is an ingredient in many brands of mouthwash and cough suppressant. It controls airway mucus hypersecretion and asthma via anti-inflammatory cytokine inhibition.
Synonyms: 1,8-epoxy-p-menthane, 1,8-oxido-p-menthaneMixtures: Keloid Healer Synergy for treatment of keloidsSomatotropin
go.drugbank.com/drugs/DB00052ApprovedInvestigational[A228188] Recombinant growth hormone is available as a subcutaneous injection for children and adults under a wide variety of brand names. … [A228183] Growth hormone therapy is approved for various disorders of growth hormone deficiency, growth failure, or short stature including Turner syndrome, chronic renal insufficiency before transplantation
Categories: P-glycoprotein substrates, Cytochrome P-450 CYP1A2 InducersProducts: ZOMACTON Powder and Solvent for Solution for Injection 10mg, ZOMACTON Powder and Solvent for Solution for Injection 4 mg